The Samuel Waxman Cancer Research Foundation (SWCRF) announced that it awarded $1.4 million in new grants to scientists conducting groundbreaking research. The grants will fund research in aging and cancer, differentiation therapy, abnormal gene expression, and epigenetic therapies.
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
